J. Papp - Concepedia

Author

J. Papp

Also Known As

Dr. J. Papp, Finn C. Nielsen, Henrik Csaba Horvath, J PAPP, J Papp, J. PAPP, J. Papp, Janos Papp, Janos. Papp, Jànos Papp

259

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Semmelweis University National Institute of Oncology University of Debrecen University of Szeged Veszprémi Érseki Hittudományi Fõiskola

About

J. Papp is an author at Semmelweis University specializing in medicine, pathology, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	777
2	Engineering	7	8	137
3	Natural Sciences	1	1	14
4	Public Health	1	1	87
5	Biochemistry	1	1	37

J. Papp

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer Timothy R. Rebbeck, Nandita Mitra, Fei Wan, JAMA	2015	484
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study Marlies Kempers, Roland P. Kuiper, Charlotte W. Ockeloen, The Lancet Oncology Cancer RiskMedicineColorectal CancerPathologyGynecology	2010	287
Deletions removing the last exon of<i>TACSTD1</i>constitute a distinct class of mutations predisposing to Lynch syndrome Marietta Eva Kovacs, J. Papp, Zoltán Szentirmay, Human Mutation	2009	168
New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort Mária Papp, I Altorjay, Nir Dotan, The American Journal of Gastroenterology	2008	146
Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn’s disease Péter L. Lakatos, Z Czeglédi, Tamás Szamosi, World Journal of Gastroenterology	2009	113
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Catherine M. Phelan, Åke Borg, Marguerite Cuny, PubMed Breast OncologyCancer PathologyGeneticsPathologyGynecology	1998	87
Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohnʼs disease Péter L. Lakatos, Lajos S. Kiss, Károly Palatka, Inflammatory Bowel Diseases	2010	81
Seroreactivity to microbial components in Crohnʼs disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients Mária Papp, I Altorjay, Gary L. Norman, Inflammatory Bowel Diseases	2007	80
Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease Ágnes K. Kocsis, Péter L. Lakatos, Ferenc Somogyvári, Scandinavian Journal of Gastroenterology	2008	74
Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohnʼs disease, while smoking decreases the risk of colectomy in ulcerative colitis Tamás Szamosi, János Banai, Z Czeglédi, European Journal of Gastroenterology & Hepatology	2010	65

Page 1